STOCK TITAN

Pacira BioSciences to Present at Two Healthcare Conferences in November

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Pacira BioSciences, Inc. (NASDAQ: PCRX) announced participation in upcoming healthcare conferences. The company will engage in an analyst-led fireside chat at the Jefferies London Healthcare Conference on November 15 at 8:00 AM GMT and the 34th Annual Piper Sandler Healthcare Conference on November 29 at 2:30 PM ET. Live audio can be accessed on their website, with replays available for two weeks post-event. Pacira is dedicated to offering non-opioid pain management options and has three commercial products for pain relief.

Positive
  • None.
Negative
  • None.

TAMPA, Fla., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (NASDAQ: PCRX) today announced that it will participate in an analyst-led fireside chat at the following two healthcare conferences:

  • Jefferies London Healthcare Conference on Tuesday, November 15th at 8:00AM GMT (3:00AM ET).
  • 34th Annual Piper Sandler Healthcare Conference on Tuesday, November 29th at 2:30PM ET.

Live audio of the events can be accessed by visiting the “Events” page of the company’s website at investor.pacira.com. A replay of the webcasts will also be available for two weeks following the events.

About Pacira         

Pacira BioSciences, Inc. (Nasdaq: PCRX) is committed to providing a non-opioid option to as many patients as possible to redefine the role of opioids as rescue therapy only. The company is also developing innovative interventions to address debilitating conditions involving the sympathetic nervous system, such as cardiac electrical storm, chronic pain, and spasticity. Pacira has three commercial-stage non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesia currently approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, injection indicated for the management of osteoarthritis knee pain; and ioveraº®, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. To learn more about Pacira, including the corporate mission to reduce overreliance on opioids, visit www.pacira.com.


FAQ

When is Pacira BioSciences participating in the Jefferies London Healthcare Conference?

Pacira BioSciences will participate in the Jefferies London Healthcare Conference on November 15, 2022, at 8:00 AM GMT.

What time is the Piper Sandler Healthcare Conference for Pacira?

The Piper Sandler Healthcare Conference featuring Pacira BioSciences is scheduled for November 29, 2022, at 2:30 PM ET.

How can I listen to the live events featuring Pacira BioSciences?

Live audio of the events can be accessed on the 'Events' page of Pacira BioSciences' website.

What products does Pacira BioSciences offer for pain management?

Pacira BioSciences offers three non-opioid treatments: EXPAREL, ZILRETTA, and ioveraº for pain management.

Pacira BioSciences, Inc.

NASDAQ:PCRX

PCRX Rankings

PCRX Latest News

PCRX Stock Data

1.14B
45.13M
2.15%
114.51%
10.29%
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States of America
TAMPA